AstraZeneca Plc has said today that its blood-thinning drug Brilinta failed to help stroke patients as hoped in a major clinical trial. Brilinta didn’t outperform aspirin in the three-month long
AstraZeneca Plc has said today that its blood-thinning drug Brilinta failed to help stroke patients as hoped in a major clinical trial. Brilinta didn’t outperform aspirin in the three-month long